•
Sep 30, 2014

Jazz Pharmaceuticals Q3 2014 Earnings Report

Total Revenue
$307M
Previous year: $232M
+32.0%
EPS
$2.33
Previous year: $1.78
+30.9%
Gross Profit
$280M
Previous year: $208M
+34.5%
Cash and Equivalents
$575M
Previous year: $588M
-2.3%
Total Assets
$3.35B
Previous year: $2.19B
+53.2%

Jazz Pharmaceuticals

Jazz Pharmaceuticals